SPRINKLR INC-A (CXM) 10.405 +0 (+0.05%)
10.405 +0 (+0.05%)
US85208T1079 - Common Stock
Fundamental Rating
Taking everything into account, CXM scores 4 out of 10 in our fundamental rating. CXM was compared to 373 industry peers in the Software industry. While CXM has a great health rating, but there are worries on its profitability. CXM is valued quite expensive, but it does show an excellent growth.
Note: CXM has only limited data available, so a full analysis was not possible, which makes the total rating unfair.
Profitability
Profitability Rating
The Piotroski-F score of CXM is 4.00. This is a neutral score and indicates average health and profitability for CXM.
VS Industry
Valuation
Valuation Rating
The PEG Ratio, which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
With a price book ratio of 5.25, CXM is valued correctly.
The Price/Earnings Ratio is negative for CXM. In the last year negative earnings were reported.
With a Forward Price/Earnings Ratio of 114.58, CXM is valued very expensively.
Compared to an average industry price book ratio of 3.41, CXM is valued more expensive than its industry peers.
VS Industry
Price/Book (5.25) VS Industry: 34% outperformed.
195.25
0.11
Growth
Growth Rating
CXM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 12.12%, which is quite good.
Based on estimates for the next 5 years, CXM will show a very strong growth in Earnings Per Share. The EPS will grow by 37.20% on average per year.
The Revenue has grown by 27.71% in the past year. This is a very strong growth!
CXM is expected to show quite a strong growth in Revenue. In the coming 5 years, the Revenue will grow by 19.76% yearly.
| Past | Future | ||||||
|---|---|---|---|---|---|---|---|
| 5Y | 3Y | 1Y | 1Y | 2Y | 3Y | 5Y | |
| EPS | N/A | N/A | 12.12% | 85.13% | 51.52% | 37.2% | N/A |
| Revenue | N/A | N/A | 27.71% | 26.39% | 20.7% | 19.76% | N/A |
Health
Health Rating
CXM has a Current Ratio of 2.06. This indicates that CXM is financially healthy and has no problem in meeting its short term obligations.
A Quick Ratio of 2.06 indicates that CXM has no problem at all paying its short term obligations.
When comparing the Debt to Equity Ratio of 0.00 to an average industry Debt to Equity of 0.06, CXM is way less dependent on financing that its industry peers.
An Altman-Z score of 4.43 indicates that CXM is not in any danger for bankruptcy at the moment.
CXM is in better financial health than average in its industry. Its Altman-Z score is much better than the industry average of 1.79.
CXM has a Current Ratio comparable to the industry average, which is at 1.76.
CXM has a Quick Ratio comparable to the industry average, which is at 1.74.
The Piotroski-F score of CXM is 4.00. This is a neutral score and indicates average health and profitability for CXM.
VS Industry
Debt/Equity (0) VS Industry: 66% outperformed.
51.02
0.00
Quick Ratio (2.06) VS Industry: 57% outperformed.
0.06
83.89
Current Ratio (2.06) VS Industry: 56% outperformed.
0.06
83.89
Altman-Z (4.43) VS Industry: 69% outperformed.
-485.88
215.75
Dividend
Dividend Rating
No dividends for CXM!.
SPRINKLR INC-A10.405
NYSE:CXM (2/2/2023, 9:04:59 AM)+0 (+0.05%)
| GICS Sector | Information Technology | ||
| GICS IndustryGroup | Software & Services | ||
| GICS Industry | Software | ||
| Earnings (Last) | 12-06 2022-12-06/amc | Earnings (Next) | N/A N/A |
| Inst Owners | 25.77% | Inst Owner Change | -0.02% |
| Ins Owners | 1.2% | Ins Owner Change | -161.6% |
| Market Cap | 2.72B | Analysts | 77.33 |
| Price Target | 11.09 (6.58%) | ||
| Dividend Yield | N/A | Dividend Growth | N/A |
| DP | N/A | Ex-Date | N/A |
| EPS beat(2) | 2 | Avg EPS beat(2) | 160.38% |
| Min EPS beat(2) | 47.05% | Max EPS beat(2) | 273.7% |
| EPS beat(4) | 4 | Avg EPS beat(4) | 96.46% |
| Min EPS beat(4) | 21.79% | Max EPS beat(4) | 273.7% |
| Revenue beat(2) | 1 | Avg Revenue beat(2) | 0.51% |
| Min Revenue beat(2) | -0.23% | Max Revenue beat(2) | 1.24% |
| Revenue beat(4) | 3 | Avg Revenue beat(4) | 1.44% |
| Min Revenue beat(4) | -0.23% | Max Revenue beat(4) | 3.03% |
| PT rev (1m) | -0.13% | PT rev (3m) | -26.89% |
| EPS NQ rev (1m) | 37.72% | EPS NQ rev (3m) | 37.72% |
| EPS NY rev (1m) | 0% | EPS NY rev (3m) | 38.86% |
| Revenue NQ rev (1m) | -2% | Revenue NQ rev (3m) | -2% |
| Revenue NY rev (1m) | 0% | Revenue NY rev (3m) | -0.38% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 114.58 | ||
| P/S | 4.62 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 5.25 | ||
| P/tB | 5.82 | ||
| EV/EBITDA | N/A |
| EPS(TTM) | -0.11 | EY | N/A |
| EPS(NY) | 0.09 | Fwd EY | 0.87% |
| FCF(TTM) | -0.09 | FCFY | N/A |
| OCF(TTM) | -0.04 | OCFY | N/A |
| SpS | 2.25 | BVpS | 1.98 |
| TBVpS | 1.79 | PEG (NY) | N/A |
| PEG (5Y) | N/A | ||
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | N/A | ||
| ROE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM | N/A | ||
| GM | 72.1% |
| ROICexgc(3y) | N/A | ROICexcg growth 3Y | N/A |
| ROICexcg growth 5Y | N/A | ROICexc(3y) | N/A |
| ROICexc growth 3Y | N/A | ROICexc growth 5Y | N/A |
| OM growth 3Y | N/A | OM growth 5Y | N/A |
| PM growth 3Y | N/A | PM growth 5Y | N/A |
| GM growth 3Y | N/A | GM growth 5Y | N/A |
| F-Score | 4 | Asset Turnover | 0.66 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 123.04% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.06 | ||
| Quick Ratio | 2.06 | ||
| Altman-Z | 4.43 |
| F-Score | 4 | WACC | 10.9% |
| ROIC/WACC | N/A | Cap/Depr(3y) | 128.3% |
| Cap/Depr(5y) | N/A | Profit Quality(3y) | N/A |
| Profit Quality(5y) | N/A | ||
| EPS 1Y | 12.12% | EPS 3Y | N/A |
| EPS 5Y | N/A | EPS growth Q2Q | 133.33% |
| EPS Next Y | 85.13% | EPS Next 2Y | 51.52% |
| EPS Next 3Y | 37.2% | EPS Next 5Y | N/A |
| Revenue growth 1Y | 27.71% | Revenue growth 3Y | N/A |
| Revenue growth 5Y | N/A | Revenue growth Q2Q | 23.77% |
| Revenue Next Year | 26.39% | Revenue Next 2Y | 20.7% |
| Revenue Next 3Y | 19.76% | Revenue Next 5Y | N/A |
| EBIT growth 1Y | 0.48% | EBIT growth 3Y | N/A |
| EBIT growth 5Y | N/A | EBIT Next Year | 120.99% |
| EBIT Next 3Y | 31.79% | EBIT Next 5Y | N/A |
| FCF growth 1Y | -5581.02% | FCF growth 3Y | N/A |
| FCF growth 5Y | N/A | OCF growth 1Y | -550.31% |
| OCF growth 3Y | N/A | OCF growth 5Y | N/A |
Fundamental Stock Screener Links
Fundamental Stock Screener
Find stocks with similar Fundamental rating on the USA
Growth Stock Screener
Find more growth stocks the USA
Best Fundamental Competitors Stock Screener
Find the competitors with the best fundamentals on the USA
Best Valuation Competitors Stock Screener
Find the competitors with the best valuation on the USA
Best Dividend Competitors Stock Screener
Find the competitors with the best dividend on the USA